Keyphrases
Acute Decompensated Heart Failure
100%
Add-on Therapy
100%
Hydralazine
100%
Isosorbide Dinitrate
100%
Cardiac Index
60%
All-cause Mortality
40%
Angiotensin Receptor Blockers
40%
Confidence Interval
40%
Odds Ratio
40%
Systemic Vascular Resistance
40%
Hemodynamic Profile
40%
Neurohormonal Blockade
40%
Angiotensin-converting Enzyme Inhibitor (ACEi)
40%
Blood Pressure
20%
Renal Function
20%
Heart Failure Hospitalization
20%
Pressure Function
20%
Demographic Characteristics
20%
African American Population
20%
Low Dose Rate
20%
Consecutive Patients
20%
Intracardiac
20%
Neurohormonal Antagonists
20%
Filling Pressure
20%
Long-term Clinical Outcome
20%
Low Output
20%
Intensive Care Medicine
20%
Clinical Outcomes
20%
Baseline Blood Pressure
20%
Nursing and Health Professions
Congestive Heart Failure
100%
Hydralazine
100%
Add on Therapy
100%
Isosorbide Dinitrate
100%
Cardiac Index
50%
Clinical Outcome
33%
Odds Ratio
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Blood Pressure
33%
Confidence Interval
33%
Systemic Vascular Resistance
33%
Angiotensin Receptor Antagonist
33%
All Cause Mortality
33%
Hemodynamic
33%
Hospital Readmission
16%
Combination Therapy
16%
Medicine and Dentistry
Isosorbide Dinitrate
100%
Decompensated Heart Failure
100%
Add on Therapy
100%
Hydralazine
100%
Hemodynamic
40%
All Cause Mortality
40%
Blood Pressure
40%
Angiotensin Receptor Antagonist
40%
ACE Inhibitor
40%
Systemic Vascular Resistance
40%
Odds Ratio
40%
Combination Therapy
20%
Kidney Function
20%
Congestive Heart Failure
20%
Oral
20%